GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,646.10
arrow_upward
+1.16%(+30.30) 1D
Nov 18, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,663.60
High
₹2,691.50
Low
₹2,625.10
Mkt. cap
746.79B
Avg. vol.
786.54K
Volume
1.09M
Dividend
0.19%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
41.55
52-wk high
₹2,714.00
52-wk low
₹1,818.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,663.60
High
₹2,691.50
Low
₹2,625.10
Mkt. cap
746.79B
Avg. vol.
786.54K
Volume
1.09M
Dividend
0.19%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
41.55
52-wk high
₹2,714.00
52-wk low
₹1,818.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
Moneycontrol.com
·
10 hours ago
Glenmark Pharma shares rise over 2% as unit files US application for experimental solid-tumour drug
Moneycontrol.com
·
14 hours ago
Glenmark's IGI files USFDA application for first-in-class solid tumour therapy
HDFC Sky
·
2 days ago
Glenmark Launches Generic INLYTA Cancer Tablets in US; Shares Rise 1.4%
Dalal Street Investment Journal
·
2 days ago
Glenmark Launches Axitinib Authorised Generic in US as Shares Trade Higher
Profile
Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company with its headquarters in Mumbai. It was founded 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, and its shares are listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations mainly in India, North America, and Europe. It had about 17,000 employees as of March 2026. Its name comes from Saldanha's sons, Glenn and Mark.
Glenmark began developing proprietary medicines in the mid-2010s. In 2025, its research arm, Ichnos Glenmark Innovation, licensed ISB 2001, an investigational treatment for multiple myeloma, to AbbVie for an upfront payment of $700 million. The U.S. Food and Drug Administration has issued warning letters to several of the company's plants in India and the United States. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees16.9K
FoundedNov 18, 1977
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteglenmarkpharma.com